Chitosan-based crosslinking for controlled topical drug release in rhinosinusitis.
Int Forum Allergy Rhinol
; 2024 Jul 11.
Article
em En
| MEDLINE
| ID: mdl-38990106
ABSTRACT
KEY POINTS Chitosan is a promising drug delivery vector for therapeutics owing to its biocompatibility. Once crosslinked with chitosan, prolonged drug release was noted regardless of hydrophilicity. Hydrophilic drugs may require different strategies to obtain a sustained release profile.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Int Forum Allergy Rhinol
Ano de publicação:
2024
Tipo de documento:
Article